EUVIMEDEUVIMED entdecken
Crossref

Does the addition of radiation to adjuvant chemotherapy improve the survival for early‐stage (tumor size ≤4 cm) small cell neuroendocrine carcinoma of the cervix after surgery? A population‐based study

Xi-Lin Yang, Zheng Zeng, Jun-Fang Yan, Fu-Quan Zhang

International Journal of Gynecology & Obstetrics · 2025-10 · 171 (1) · 362-370

DOI: 10.1002/ijgo.70192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 07.05.2025. Verfasst von Xi-Lin Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Carcinoma, Neuroendocrine, Carcinoma, Small Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To assess the potential benefit of adding radiotherapy to adjuvant chemotherapy in patients with early‐stage small cell neuroendocrine carcinoma of the cervix (SCNEC) (tumor size ≤4 cm) after surgery.

Methods

The Surveillance, Epidemiology, and End Results (SEER) database was queried for patients with early‐stage SCNEC who received primary surgery and at least adjuvant chemotherapy from 1988 to 2018. Eligible patients were categorized into radiation and nonradiation group, survival outcomes were compared before and after propensity scoring matching (PSM). Cox regression analysis was used to identify risk factors in the nonradiation group. Accordingly, a scoring system was constructed to select patients who might benefit from the addition of radiation.

Results

No statistically significant difference in overall survival was observed between the two groups whether before or after PSM ( P > 0.05). However, the nonradiation group exhibited better survival outcomes than the radiation group for patients aged ≤50 years ( P = 0.035) and patients receiving modified/radical hysterectomy ( P = 0.031). Conversely, patients with stage T2a1 disease obtained greater benefit from radiation compared with nonradiation ( P = 0.016). A scoring system incorporating T stage, tumor size, and number of lymph nodes examined during surgery was developed to stratify patients into low‐risk (total points ≤27.9) and high‐risk (total points >27.9) groups. Notably, patients in the high‐risk group had improved outcomes with the addition of radiotherapy ( P = 0.0052).

Conclusion

The addition of radiation to adjuvant chemotherapy did not confer a survival benefit for every patient with early‐stage SCNEC, except for those with stage T2a1 disease. Moreover, a scoring system was developed to preliminarily identify patients who might benefit from the addition of radiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsCarcinoma, NeuroendocrineCarcinoma, Small CellHumansFemaleMiddle AgedSEER ProgramChemotherapy, AdjuvantNeoplasm StagingAdultHysterectomyRadiotherapy, AdjuvantAgedRetrospective StudiesPropensity Score

Stichwörter der Autor:innen

additional radiationadjuvant chemotherapyscoring systemsmall cell neuroendocrine carcinoma of cervixtumor size ≤4 cm

Autor:innen und Institutionen

  • Department of Radiation Oncology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Re…

Zitieren

APA

Yang, X. L., Zeng, Z., Yan, J. F., & Zhang, F. Q. (2025). Does the addition of radiation to adjuvant chemotherapy improve the survival for early‐stage (tumor size ≤4 cm) small cell neuroendocrine carcinoma of the cervix after surgery? A population‐based study. International Journal of Gynecology & Obstetrics, 171(1), 362-370. https://doi.org/10.1002/ijgo.70192

Vancouver

Yang XL, Zeng Z, Yan JF, Zhang FQ. Does the addition of radiation to adjuvant chemotherapy improve the survival for early‐stage (tumor size ≤4 cm) small cell neuroendocrine carcinoma of the cervix after surgery? A population‐based study. International Journal of Gynecology & Obstetrics. 2025;171(1):362-370. doi:10.1002/ijgo.70192

BibTeX
@article{Yang2025,
  author = {Yang, Xi-Lin and Zeng, Zheng and Yan, Jun-Fang and Zhang, Fu-Quan},
  title = {Does the addition of radiation to adjuvant chemotherapy improve the survival for early‐stage (tumor size ≤4 cm) small cell neuroendocrine carcinoma of the cervix after surgery? A population‐based study},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  volume = {171},
  number = {1},
  pages = {362--370},
  doi = {10.1002/ijgo.70192}
}
Kostenlos starten →